Safety, pharmacokinetics and pharmacodynamics of AMG 811, an anti-interferon-γ monoclonal antibody, in SLE subjects without or with lupus nephritis (14 September, 2017)
Lupus Science & Medicine is a global, peer reviewed, Open Access online journal that provides a central point for publication of basic, clinical, translational, and epidemiological studies of all aspects of lupus and related diseases. It is the first lupus-specific Open Access journal in the world and has been developed in response to the need for a barrier-free forum for publication of groundbreaking studies in lupus.
An official journal of the Lupus Foundation of America (LFA), which is dedicated to advancing the science and medicine of lupus while offering support to patients and their caregivers.
This home page is under development
Correction: Single-cell gene expression patterns in lupus monocytes independently indicate disease activity, interferon and therapy (11 September, 2017)
Correlation of hypogammaglobulinaemia with proteinuria, and the relationship between hypogammaglobulinaemia and infection in active lupus nephritis (31 August, 2017)
Thank you to our reviewers 2016 (21 August, 2017)
Cell-bound complement activation products in SLE (21 August, 2017)
Use of SLICC criteria in a large, diverse lupus registry enables SLE classification of a subset of ACR-designated subjects with incomplete lupus (17 March, 2017)
Epidemiology and outcomes:
Strong viral associations with SLE among Filipinos (28 July, 2017)
Clinical trials and drug discovery:
The use of rituximab in newly diagnosed patients with systemic lupus erythematosus: long-term steroid saving capacity and clinical effectiveness (2 February, 2017)
Osteopontin is associated with disease severity and antiphospholipid syndrome in well characterised Swedish cases of SLE (28 July, 2017)